arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Pluri Inc.

PLUR
$1.24 0.00 (0.00%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
18 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Pluri Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $12.1M
Dividend Yield —
Revenue Growth -24.0% ↘
Op. Margin —
ROIC 108.2% ↘
FCF / Share $-2.08 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 3, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.02M
↓ -24.0% —
Net Income Profit after all expenses
$-23.82M
↓ -5.5% —
FCF / Share Free cash flow per share
$-2.08
↑ +33.7% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
98
Cash Quality →
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 66 quarters